Role for topical immunotherapy in metastatic melanoma 26 Aug 2011 0 comments A Sydney patient with extensive metastatic melanoma has experienced remarkable cancer regression on topical immunotherapy and silver sulfadiazine, dermatologists report.
Ipilimumab not recommended for PBS 26 Aug 2011 0 comments The Pharmaceutical Benefits Advisory Committee has rejected a submission for the PBS-listing of ipilimumab for malignant melanoma.
